Asia-Pacific Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Asia-Pacific Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026
SUMMARY
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology market had total revenues of $249.9 billion in 2021, representing a compound annual growth rate (CAGR) of 15.2% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $126.5 billion, equivalent to 50.6% of the market's overall value.
- The Indian market is the largest in the Asia-Pacific region, accounting for 38% of its total value in 2021. The Indian market has experienced some of the strongest growth rates in the region in recent years, as it develops in maturity.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts by both value and volume
- What was the size of the Asia-Pacific biotechnology market by value in 2021?
- What will be the size of the Asia-Pacific biotechnology market in 2026?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.3. Shanghai Kehua Bio-engineering Co Ltd
8.4. Astellas Pharma Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Takeda Pharmaceutical Company Limited
8.2. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.3. Shanghai Kehua Bio-engineering Co Ltd
8.4. Astellas Pharma Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
Table 2: Asia–Pacific biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Asia–Pacific biotechnology industry geography segmentation: $ billion, 2021
Table 5: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 11: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 13: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 14: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 15: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2017–21
Table 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
Table 2: Asia–Pacific biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Asia–Pacific biotechnology industry geography segmentation: $ billion, 2021
Table 5: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 11: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 13: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 14: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 15: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Asia-Pacific exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Asia–Pacific biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2021
Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
Figure 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Asia–Pacific biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2021
